Atlas of Retinal Imaging in Alzheimer's Study
Public ClinicalTrials.gov record NCT03862222. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT03862222
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- University of Rhode Island
- Other
- Enrollment
- 165 participants
Conditions and interventions
Interventions
- Retinal Imaging Other
- Pupillometry Other
- Contrast Sensitivity Other
- Neuropsychological Evaluation Diagnostic Test
- APOE genotyping Genetic
- blood draw Other
- Gait Assessment Other
- Actigraphy Other
Other · Diagnostic Test · Genetic
Eligibility (public fields only)
- Age range
- 55 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 15, 2019
- Primary completion
- Dec 30, 2022
- Completion
- May 30, 2025
- Last update posted
- Jun 4, 2025
2019 – 2025
United States locations
- U.S. sites
- 4
- U.S. states
- 2
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Morton Plant Hospital | Clearwater | Florida | 33756 | — |
| St. Anthony's Hospital | St. Petersburg | Florida | 33705 | — |
| University of Rhode Island | Kingston | Rhode Island | 02881 | — |
| Butler Hospital | Providence | Rhode Island | 02906 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03862222, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03862222 live on ClinicalTrials.gov.